Contract Manufacturer Enquiry: What to Include

Contract Manufacturer Enquiry: What to Include

20/10/2026

10

Jorit Tessmann

Jorit Tessmann

CEO & Founder at Labtree GmbH

A reliable quotation only emerges from a complete enquiry: target price, quantity per SKU, timeline, benchmark, packaging, target markets and claims determine the formulation, the scope of testing and the minimum order quantity. If this information is missing, the manufacturer calculates on assumptions.

The topic is short and compact

Target price, quantity per SKU, initial and follow-up volumes and the timeline belong in the first enquiry, otherwise the manufacturer calculates on assumptions.

Annex I of Regulation (EC) No 1223/2009 makes application, exposure, user group and packaging input parameters of the safety assessment.

Mandatory label information is harmonised across the EU; only the language is regulated nationally per target country (Art. 19(5)).

Advertising claims must be truthful and substantiated; Regulation (EU) No 655/2013 sets out six criteria of equal importance.

For a shelf life of more than 30 months, the period-after-opening is indicated instead of the best-before date, where relevant (Art. 19(1)(c)).

So läuft die Entwicklung bei Labtree

1

Konzeptionierung

2

Bemusterung – Standardmuster in 24 h

3

Individualisierung

4

Prototyping

5

Produktion

White Label 2–3 Monate · Private Label 3–6 Monate · Produktion ab 1.000 Stück

Why does the enquiry determine the quality of the quotation?

A quotation is only as good as the data it is based on. The manufacturer builds the target price, quantity, application and packaging directly into formulation design, testing scope and development route. If these key figures are missing, the manufacturer calculates on assumptions — and every assumption that later has to be corrected costs rework in the laboratory, in procurement or in costing. For an independent brand with a limited budget, this is the difference between a reliable cost estimate and a figure that crumbles as the project progresses.

From the enquiry, the manufacturer derives in concrete terms which formulation logic, which testing scope and which development route are viable:

  • From the target retail price: the unit costs calculated backwards, and from those the formulation effort and packaging level.

  • From the quantity per SKU: the manufacturing process, batch size and the question of whether the development effort pays off at all.

  • From application and user group: exposure, assessment framework and scope of the safety assessment.

  • From the packaging: compatibility testing, filling process and minimum order quantities for components.

Application, user group and packaging are not soft descriptions here, but input variables for the safety assessment under Annex I of Regulation (EC) No 1223/2009. Anyone who provides this information only after the quotation changes the regulatory basis of the product retroactively. A cost estimate can only be properly reviewed if these items are included from the start; the guide to the contract manufacturer's quotation shows which items must be visible in it.

Which commercial key figures belong in the enquiry?

Four pieces of information form the commercial framework of every enquiry: target retail price, quantity per SKU, initial and follow-up quantities, and the schedule. They determine which formulation logic, which manufacturing process and which development route are viable at all. All four can be stated even when the product is not yet defined in detail, because they are target values, not final specifications.

  • Target retail price: unit costs, formulation design and packaging are calculated backwards from the intended retail price. A skin tint with a low RRP tolerates a different formulation and packaging logic than a complexion product in the premium segment.

  • Quantity per SKU: it determines batch size, manufacturing process and whether formulation and testing effort pays off for this single item number.

  • Initial and follow-up quantities: the initial quantity carries development, sampling and tooling; the follow-up quantities show whether investment in shades or components is worthwhile.

  • Schedule: it must include stability testing as a separate milestone, because only this determines the best-before date or the period after opening under Art. 19(1)(c) of Regulation (EC) No 1223/2009.

The minimum order quantity is usually 1,500 units per product, depending on product type, fill size and packaging. Anyone who states this order of magnitude at first contact receives a quotation on a realistic basis rather than on a hypothetical unit count. How a budget can be planned across an entire line is described in the article on the cost of a private label cosmetics line; which tests belong in the schedule is covered in the article on stability and safety testing.

How do you describe product, application and target group?

The product description in the enquiry is a technical basis, not marketing copy. The manufacturer must be able to identify product type, texture, area of application and user group from it in order to define the formulation approach and testing scope. A paragraph of positioning language does not help; a structured description does.

A benchmark product is the most effective tool here. It translates subjective wishes about texture, finish and performance into a technically usable brief: instead of vague adjectives, there is a concrete reference product whose viscosity, coverage and payoff can be reproduced in the laboratory. This includes stating what is to be matched and what is to be exceeded.

  • Product type and category: concrete categories instead of generic terms — skin tint, concealer, blush or mascara for make-up; serums, creams, cleansers or masks for skincare.

  • Benchmark: a concrete reference product, stating which properties are to be matched or exceeded.

  • Desired texture and sensorics: viscosity, application, finish, payoff, if preferences already exist.

  • Area of application: face, lips, eye area or body, plus the expected frequency of use.

  • User group: age, skin type and particular sensitivities, as far as known.

This information is also part of the safety assessment's evaluation parameters: area of application, exposure and user group determine which test conditions the safety assessor must apply. A mascara for the eye area, a cleansing gel for daily use and a cream for sensitive skin lead to different assessment scenarios. Anyone who specifies the user group only after the quotation changes the safety assessment, not just the target group positioning.

Why does packaging belong in the enquiry from the start?

Packaging is the underestimated lever in an enquiry because it determines technology, testing effort and commerciality at the same time. Formulation, applicator, filling process and stability have to work together, and this fit is tested, not assumed. A product that is stable in the laboratory in a glass jar behaves differently in an airless system or in a hot-pour stick.

  • Testing scope: the packaging determines the compatibility testing between formulation and container, for example with airless systems, mascara wipers or hot-pour sticks.

  • Safety assessment: the packaging is also part of the safety assessment, because interactions between formulation and container must be evaluated.

  • Minimum order quantity: packaging type and fill size influence the minimum order quantity, because component suppliers have their own minimum purchase volumes.

  • Filling process: hot pouring for sticks, wiper and viscosity matching for mascara, dosing accuracy for airless systems.

A packaging change after the quotation phase is not a swap of two article numbers. It can alter preservation, viscosity, filling speed and testing scope, and with them the formulation and the cost calculation. Anyone who names the packaging, or at least the packaging format, in the enquiry receives quotations that describe the same technical state and can genuinely compare quotations from different manufacturers.

Which target markets and claims need to be fixed early?

Target markets and claims are regulatory input variables, not sales details for later. They determine labelling, durability indication and the evidence base, and all three converge in the product information file. A target market added after the quotation is therefore not a sales update but a change to label, artwork and documentation.

  • Labelling language: the mandatory information is regulated uniformly across the EU; only the language is set nationally per target country (Art. 19(5) Regulation (EC) No 1223/2009). Every additional target country means artwork and label variants.

  • Durability: with a best-before date beyond 30 months, the best-before date is omitted and the period after opening (PAO) is indicated instead, where relevant (Art. 19(1)(c)). Which indication is possible follows from the stability testing.

  • Claims: advertising claims must be truthful and substantiated. Regulation (EU) No 655/2013 establishes common criteria for substantiating advertising claims and applies to all claims, regardless of medium. The evidence is documented in the product information file.

A claim such as long wear on the skin or a free-from claim triggers tests that cost time and budget. Anyone who names it in the enquiry gets the testing effort calculated into the quotation instead of discovering it as additional costs mid-project. The labelling obligations under Art. 19 are covered in depth in the magazine article on cosmetic labelling, and the evidence base for label claims in the article on advertising claims in the EU.

How do you recognise that your enquiry is complete?

A complete enquiry can be checked against nine points. Each point triggers a concrete decision at the manufacturer, and that is exactly what shows whether the enquiry is ready for a quotation:

  1. Target retail price: sets unit costs, formulation structure and packaging level.

  2. Quantity per SKU: determines batch size and manufacturing process.

  3. Initial quantity: carries development, sampling and tooling.

  4. Follow-up quantities: justify investment in shades or components.

  5. Schedule: includes stability testing as its own milestone.

  6. Benchmark product and desired texture: translate subjective wishes into concrete laboratory work.

  7. Area of application and user group: are input variables for the safety assessment.

  8. Packaging or packaging format: determines testing scope, filling process and minimum purchase volumes.

  9. Target markets with labelling language, plus planned claims with their evidence base: define artwork, PAO logic and testing effort.

The typical gaps are claims without evidence, target markets without a labelling language decision under Art. 19(5), and a schedule without a stability window. All three create assumptions at the manufacturer that are invisible in the quotation and surface in the project as rework. An enquiry that names all nine points, by contrast, is comparable: two quotations then rest on the same assumptions, and the difference between them is performance, not interpretation.

How does an enquiry become a product briefing?

How does an enquiry become a product briefing?

How does an enquiry become a product briefing?

The inquiry is the rough draft, the product briefing the reviewed document. In the initial consultation, feasibility, budget and timeline are aligned; the inquiry is matched to suitable products and formulas, resulting in a development path with realistic next steps. Production capacities, raw material stocks and packaging availability are already checked in this phase, not only after the order is placed. In the conversation, open points from the inquiry become concrete questions, and the answers become the briefing.

As a B2B cosmetics developer and cosmetics manufacturer, Labtree is organized so that formula development, in-house laboratory work, sampling, manufacturability testing and cosmetics production lie in one process. Information from the inquiry is therefore not passed on to third parties but goes directly into laboratory work, and questions from the laboratory flow back into the briefing. Brands that already state their target price, quantity per SKU, packaging, target markets and claims in the inquiry do not start from zero there, but with a briefing that development can take up immediately.

For the first contact, conception is the starting point: it matches the inquiry to suitable products and formulas and turns it into a development path with realistic next steps. Labtree's conception takes in inquiries in exactly the structure described in the sections above and translates them into a feasibility check, budget framework and timeline.

Quellen

FAQ

Who owns the formulation after development?

In genuine contract manufacturing, the formulation remains the property of the brand, unlike a ready-made White Label formulation, where the brand takes over and adapts a tested formulation from the manufacturer. With Private Label, the formulation is developed from scratch according to the brand's requirements; rights and exclusivity are governed contractually. Clarify the ownership question in the enquiry itself.

What minimum order quantity should I plan for in the enquiry?

Labtree's minimum order quantity is usually 1,500 units per product. The exact quantity depends on product type, fill size and packaging. State the quantity per SKU as well as initial and follow-up quantities in the enquiry so the minimum order quantity can be set realistically.

Do I need a benchmark product for the enquiry?

No, but a benchmark helps considerably. Details on the texture, finish, performance, target price or positioning of a reference product translate subjective preferences into a technically usable briefing. This allows the manufacturer to match suitable formulations and sample earlier.

Why does the manufacturer ask for the target retail price before the formulation?

Unit costs are calculated backwards from the target retail price: formulation structure, packaging and production effort must fit the price. Without a target price, either the product is specified too premium and becomes too expensive, or too lean and the formulation fails to achieve the desired result.

Does the packaging have to be decided at the enquiry stage?

No, but the format and preferred packaging should be stated. The packaging determines compatibility testing, the filling process and the minimum order quantity, because formulation, applicator and stability have to work together. The packaging is also part of the safety assessment under Annex I of Regulation (EC) No 1223/2009.

What happens if target markets or claims are missing from the enquiry?

They are then set as assumptions and revised later. The mandatory labelling information is harmonised across the EU; only the language is regulated nationally per target country (Art. 19(5) of Regulation (EC) No 1223/2009). Claims must be truthful and substantiated under Regulation (EU) No 655/2013; unverified claims cause rework in formulation and documentation.

Is a short email with the product idea enough to get a quote?

For an initial assessment, yes; for a reliable quote, no. In the initial consultation, feasibility, budget, and timeline are coordinated, and details regarding quantity, packaging materials, target markets, and claims are added. This results in a product briefing, on the basis of which formulation, sampling, and production are planned.

Subscribe to our newsletter

Get more helpful information about cosmetics development.

Subscribe to our newsletter

Get more helpful information about cosmetics development.

Subscribe to our newsletter

Get more helpful information about cosmetics development.

Now discover more articles

Contact us!

>